 |
|
New perspectives of biomarkers for the management of chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol. 2016;22(4):423-431. Published online 2016 Dec 25 DOI: https://doi.org/10.3350/cmh.2016.0069
|
|
Citations to this article as recorded by
 Associations of hepatitis B and C in women aged 15–49 years with neonatal preterm birth in 66 high‐income countries, 1990–2019
Guiying Cao, Jue Liu, Min Liu
International Journal of Gynecology & Obstetrics.2024; 164(1): 115. CrossRef Precision Management of Patients with HBV Infection
Chih-Lin Lin, Jia-Horng Kao
Current Hepatology Reports.2024; 23(1): 22. CrossRef Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals
Soo Young Hwang, Sung Hwan Yoo, Hye Young Chang, Sora Kim, Jung Il Lee, Kwan Sik Lee, Young Youn Cho, Kim Hyung Joon, Hyun Woong Lee
Journal of Viral Hepatitis.2023; 30(1): 39. CrossRef Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Clinical and Molecular Hepatology.2023; 29(3): 605. CrossRef Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Gure, Secil Demirkol-Canli
Biology.2023; 12(2): 188. CrossRef Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription
Xiazhen Xu, Lu Zhang, Guiying Ye, Jiajian Shi, Yibin Peng, Fan Xin, Yi Lin, Qiong Wu, Xu Lin, Wannan Chen, J.-H. James Ou
Journal of Virology.2023;[Epub] CrossRef Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review
Nathália Alves Araujo de Almeida, Vanessa Salete de Paula
Journal of Applied Microbiology.2022; 132(3): 1616. CrossRef Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma
Mi Na Kim, Beom Kyung Kim, Yun Ho Roh, Na Ryung Choi, Su Jong Yu, Seung Up Kim
Clinical Gastroenterology and Hepatology.2022; 20(8): 1877. CrossRef Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young-Suk Lim
Journal of Clinical Investigation.2022;[Epub] CrossRef Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study
Baiguo Xu, Anjing Liu, Ying Liu, Tao Han, Hua Guo, Xian Ding, Huiling Xiang
Journal of International Medical Research.2022; 50(10): 030006052211307. CrossRef Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B
Issam Tout, Pietro Lampertico, Thomas Berg, Tarik Asselah
Antiviral Research.2021; 185: 104992. CrossRef Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
Alicia Vachon, Carla Osiowy
Viruses.2021; 13(6): 951. CrossRef Editorial: HBV cure—the quest for biomarkers to predict off‐treatment sustained response
Vincent Thibault, Tarik Asselah
Alimentary Pharmacology & Therapeutics.2021; 53(4): 552. CrossRef Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi
Ian Baudi, Takako Inoue, Yasuhito Tanaka
International Journal of Molecular Sciences.2020; 21(3): 949. CrossRef Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2020; 11(3): e00140. CrossRef An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well‐controlled viremia
Hye W. Lee, Soo Y. Park, Myeongjee Lee, Eun J. Lee, Jinae Lee, Seung U. Kim, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Beom K. Kim
Liver International.2020; 40(7): 1736. CrossRef Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir
Romuald Cruchet, Lorenza N C Dezanet, Sarah Maylin, Audrey Gabassi, Hayette Rougier, Patrick Miailhes, Caroline Lascoux-Combe, Julie Chas, Pierre-Marie Girard, Constance Delaugerre, Karine Lacombe, Anders Boyd
Open Forum Infectious Diseases.2020;[Epub] CrossRef Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients
Bei Jiang, Rui Su, Doudou Ren, Xiaoya Zheng, Yu Cao, Yuqiang Mi, Fengmei Wang, Ping Ma
Virus Research.2020; 290: 198117. CrossRef Biomarkers for hepatitis B virus replication: an overview and a look to the future
Feng-Cai Li, Yue-Kai Li, Yu-Chen Fan
Expert Review of Gastroenterology & Hepatology.2020; 14(12): 1131. CrossRef Quantification of Antibody to Hepatitis B Core Antigen to Predict Outcomes of Patients With HBV Infection
Young-Suk Lim
Clinical Gastroenterology and Hepatology.2019; 17(1): 39. CrossRef Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
Hye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang‐Hyub Han, Beom Kyung Kim, Seung Up Kim
Liver International.2019; 39(1): 81. CrossRef Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy
Meng-Lan Wang, Rong Deng, En-Qiang Chen, Chuan-Min Tao, Juan Liao, Tao-You Zhou, Juan Wang, Hong Tang
Clinics and Research in Hepatology and Gastroenterology.2019; 43(3): 301. CrossRef Analysis of serum hepatitis B virus RNA levels in a multiethnic cohort of pregnant chronic hepatitis B carriers
Nishi H. Patel, Shivali S. Joshi, Keith C.K. Lau, Eliana Castillo, Carla S. Coffin
Journal of Clinical Virology.2019; 111: 42. CrossRef Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA
En‐Qiang Chen, Meng‐Lan Wang, Ya‐Chao Tao, Dong‐Bo Wu, Juan Liao, Min He, Hong Tang
Journal of Viral Hepatitis.2019; 26(5): 586. CrossRef Establishment of an analysis model based on measurement of hepatitis B viral infection serum markers
Yang Guang, Li Yuzhong, Liu Hui
BMC Infectious Diseases.2019;[Epub] CrossRef Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
Hye Won Lee, Seung Up Kim, Oidov Baatarkhuu, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Scientific Reports.2019;[Epub] CrossRef High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2019; 50(2): 215. CrossRef External validation of the modified PAGE‐B score in Asian chronic hepatitis B patients receiving antiviral therapy
Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
Liver International.2019; 39(9): 1624. CrossRef The Role of Hepatitis B Core-Related Antigen
Takako Inoue, Yasuhito Tanaka
Genes.2019; 10(5): 357. CrossRef Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
Hye Won Lee, Seung Up Kim, Jun Yong Park, Oidov Baatarkhuu, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2019; 10(6): e00036. CrossRef Roadmap to functional cure of chronic hepatitis B: An expert consensus
Qin Ning, Di Wu, Gui-Qiang Wang, Hong Ren, Zhi-Liang Gao, Peng Hu, Mei-Fang Han, Yan Wang, Wen-Hong Zhang, Feng-Min Lu, Fu‐Sheng Wang
Journal of Viral Hepatitis.2019; 26(10): 1146. CrossRef Zeaxanthin Dipalmitate in the Treatment of Liver Disease
Nisma Lena Bahaji Azami, Mingyu Sun
Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1. CrossRef The epidemiology of hepatitis B virus infection in Korea
Sun Young Yim, Ji Hoon Kim
The Korean Journal of Internal Medicine.2019; 34(5): 945. CrossRef Hepatitis B and Delta: clinical aspects of patients in the Brazilian Western Amazonia
Marcelo Siqueira de Oliveira, Romeu Paulo Martins Silva, Suiane da Costa Negreiros do Valle, Rodrigo Medeiros de Souza, Elisabeth Níglio de Figueiredo, Mônica Taminato, Dayana Souza Fram
Revista Brasileira de Enfermagem.2019; 72(5): 1265. CrossRef High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
Tai-Chung Tseng, Chun-Jen Liu, Chen-Yang Hsu, Chun-Ming Hong, Tung-Hung Su, Wan-Ting Yang, Chi-Ling Chen, Hung-Chih Yang, Yen-Tsung Huang, Stephanie Fang-Tzu Kuo, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Gastroenterology.2019; 157(6): 1518. CrossRef Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?
Jia-Horng Kao, Thomas Berg
Gut.2019; 68(12): 2105. CrossRef Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
Liver International.2018; 38(1): 68. CrossRef Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy
Meng-Lan Wang, Juan Liao, Bing Wei, Dong-Mei Zhang, Ming He, Ming-Chuan Tao, En-Qiang Chen, Hong Tang
Infectious Diseases.2018; 50(7): 522. CrossRef Three types of preS1 start codon deletion variants in the natural course of chronic hepatitis B infection
Won Hyeok Choe, Hong Kim, So‐Young Lee, Yu‐Min Choi, So Young Kwon, Hee Won Moon, Mina Hur, Bum‐Joon Kim
Journal of Gastroenterology and Hepatology.2018; 33(7): 1370. CrossRef High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee
Gut.2018; 67(5): 945. CrossRef Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia
World Journal of Gastroenterology.2018; 24(17): 1825. CrossRef Global HBV burden: guesstimates and facts
Dina Ginzberg, Robert J. Wong, Robert Gish
Hepatology International.2018; 12(4): 315. CrossRef Hepatitis B: From control to cure
Jia-Horng Kao
Journal of the Formosan Medical Association.2018; 117(10): 868. CrossRef HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
Bhawna Poonia, Natarajan Ayithan, Madhuparna Nandi, Henry Masur, Shyam Kottilil
Scientific Reports.2018;[Epub] CrossRef Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace
Chih-Lin Lin, Jia-Horng Kao
Hepatology International.2017; 11(1): 31. CrossRef Unmet Needs in Clinical and Basic Hepatitis B Virus Research
Tung-Hung Su, Jia-Horng Kao
The Journal of Infectious Diseases.2017; 216(suppl_8): S750. CrossRef Quantitative Hepatitis B Surface Antigen in Different Phases of Chronic HBV Infection in Vietnamese Patients: The Preliminary Study
Huong Nguyen, Hang Le, Nhu Bao, Salma Fala, Ibrahim Radwan, Huy Nguyen, Hoa Pham
MedPharmRes.2017; 1(1): 2. CrossRef
|